News

The Latvian Medicines Verification Organisation (LZVO) has compiled the performance indicators of the Latvian Medicines Verification System (LZVS) for the 1st quarter of 2023 regarding the transactions made in the system, end-users and alerts and their most frequent causes.

On April 20 and 21 of this year, the Latvian Medicines Verification Organisation (LZVO) in cooperation with Arvato Systems GmbH in Riga organized two-day working group seminars for Quality and IT Operations Managers of National Medicines Verification Organisations (NMVOs) to evaluate the achieved results and plan the further development of the medicines verification system.

The European Medicines Verification Organisation (EMVO) has launched a newsletter, which looks back on the past four years of the verification system’s operation, informs about the launch of the European Alert Management System (EAMS) and provides an opportunity to look into the first European Medicines Verification System’s (EMVS) forum, which was also attended by the Latvian Medicines Verification Organisation (LZVO) representatives Inese Erdmane and Andra Pučko.

On March 23, 2023, a General Assembly of the Latvian Medicines Verification Organisation (LZVO) was held, where the report on the most significant work done in 2022 was presented, as well as the most pressing issues related to the verification system were discussed.

On February 22, the Latvian Medicines Verification Organisation (LZVO) held a free seminar for manufacturers of medicines or marketing authorization holders (MAH) on the current developments related to the medicines verification system in Latvia and a look back on what was done in 2022.

To inform marketing authorization holders (MAHs) about the current events, the Latvian Medicines Verification Organisation (LZVO) will hold a special seminar on February 22, 2023.